EVH

4.32

1.41% 0.06

Handel nachbörslich: 4.32

Evolent Health Inc (EVH)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt EVH? Forum Prognose

Schlusskurs vom Vortag:

$4.26

Offen:

$4.23

24-Stunden-Volumen:

1.48M

Relative Volume:

0.49

Marktkapitalisierung:

$488.42M

Einnahmen:

$1.89B

Nettoeinkommen (Verlust:

$-496.52M

KGV:

-0.9076

EPS:

-4.7598

Netto-Cashflow:

$1.40M

1W Leistung:

-6.09%

1M Leistung:

+38.91%

6M Leistung:

+21.69%

1J Leistung:

-54.48%

1-Tages-Spanne:

$4.15

$4.345

1-Wochen-Bereich:

$4.065

$4.535

52-Wochen-Spanne:

$2.095

$10.08

Evolent Health Inc Stock (EVH) Company Profile

Firmenname

Evolent Health Inc

Sektor

Healthcare (1074)

Branche

Health Information Services (47)

Telefon

571-389-6000

Adresse

1812 NORTH MOORE ST, SUITE 1705, ARLINGTON

Mitarbeiter

4,200

Twitter

@EvolentHealth

Nächster Verdiensttermin

2026-08-06

Neueste SEC-Einreichungen

EVH's Discussions on Twitter

Compare EVH vs VEEV, BTSG, TEM, TXG, HQY

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
EVH Evolent Health Inc	4.32	531.38M	1.89B	-496.52M	1.40M	-4.7598
VEEV Veeva Systems Inc	275.09	40.70B	3.32B	941.65M	1.64B	5.6161
BTSG Brightspring Health Services Inc	60.73	11.78B	13.65B	169.86M	412.12M	1.0758
TEM Tempus Ai Inc	64.62	12.03B	1.36B	-302.91M	-219.93M	-1.7182
TXG 10 X Genomics Inc	62.65	8.32B	638.78M	-22.66M	122.18M	-0.1744
HQY Healthequity Inc	96.07	8.72B	1.34B	230.70M	440.96M	2.6695

Evolent Health Inc Stock (EVH) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2026-02-25	Herabstufung	KeyBanc Capital Markets	Overweight → Sector Weight
2025-11-13	Eingeleitet	BMO Capital Markets	Outperform
2025-11-13	Hochstufung	Stephens	Equal-Weight → Overweight
2025-01-10	Eingeleitet	Needham	Buy
2024-12-03	Bestätigt	BTIG Research	Buy
2024-11-08	Herabstufung	Stephens	Overweight → Equal-Weight
2024-10-11	Eingeleitet	KeyBanc Capital Markets	Overweight
2024-08-09	Hochstufung	Truist	Hold → Buy
2024-04-22	Eingeleitet	Citigroup	Buy
2024-03-01	Eingeleitet	Oppenheimer	Outperform
2024-01-03	Eingeleitet	Barclays	Overweight
2023-12-06	Eingeleitet	JMP Securities	Mkt Outperform
2023-10-16	Eingeleitet	UBS	Buy
2023-04-12	Eingeleitet	Stephens	Overweight
2022-11-01	Eingeleitet	Truist	Hold
2022-07-29	Eingeleitet	RBC Capital Mkts	Outperform
2022-03-30	Eingeleitet	Guggenheim	Buy
2021-11-18	Hochstufung	JP Morgan	Neutral → Overweight
2021-04-29	Fortgesetzt	JP Morgan	Neutral
2021-01-07	Eingeleitet	BTIG Research	Buy
2020-07-06	Herabstufung	KeyBanc Capital Markets	Overweight → Sector Weight
2020-06-05	Herabstufung	Goldman	Buy → Neutral
2020-06-02	Herabstufung	Cantor Fitzgerald	Overweight → Neutral
2018-10-05	Fortgesetzt	Leerink Partners	Outperform
2018-06-04	Eingeleitet	Piper Jaffray	Overweight
2018-04-24	Fortgesetzt	JP Morgan	Neutral
2017-09-20	Eingeleitet	KeyBanc Capital Mkts	Overweight
2017-06-02	Eingeleitet	Robert W. Baird	Outperform
2017-03-14	Eingeleitet	Oppenheimer	Outperform
2017-01-13	Hochstufung	Wells Fargo	Market Perform → Outperform
2016-10-28	Fortgesetzt	JP Morgan	Overweight
2016-08-05	Bestätigt	FBR Capital	Outperform
2016-07-26	Eingeleitet	Jefferies	Buy
2016-07-13	Bestätigt	FBR Capital	Outperform
2016-03-29	Eingeleitet	FBR Capital	Outperform
2016-01-06	Eingeleitet	Canaccord Genuity	Buy
2015-06-30	Eingeleitet	Goldman	Buy
2015-06-30	Eingeleitet	JP Morgan	Overweight
2015-06-30	Eingeleitet	Leerink Partners	Outperform
2015-06-30	Eingeleitet	Sun Trust Rbsn Humphrey	Buy

Alle ansehen

Evolent Health Inc Aktie (EVH) Neueste Nachrichten

Aug 30, 2026

EVH | Evolent Health, Inc Class FinancialsRevenue Breakdown - Quiver Quantitative

Aug 23, 2026

Aug 20, 2026

EVH Stock On Track To Open At Record Low – Here’s Why Keybanc Turned Cautious - Stocktwits

Aug 20, 2026

Aug 18, 2026

EVH Maintains Overweight Rating by JP Morgan -- Price Target Rai - GuruFocus

Aug 18, 2026

Aug 17, 2026

EVH Maintained by TD Cowen -- Price Target Raised to $6.00 - GuruFocus

Aug 17, 2026

Aug 16, 2026

TD Cowen Maintains Evolent Health(EVH.US) With Buy Rating, Raises Target Price to $6 - Moomoo

Aug 16, 2026

1 Healthcare Stock Worth Your Attention and 2 We Brush Off - Yahoo Finance UK

Aug 16, 2026

Aug 14, 2026

5 Must-Read Analyst Questions From Evolent Health’s Q2 Earnings Call - Yahoo Finance

Aug 14, 2026

Aug 13, 2026

Evolent Health (NYSE:EVH) Shares Up 10%What's Next? - marketbeat.com

Aug 13, 2026

Evolent Health (EVH) Q2 2026 Earnings Call Transcript - The Globe and Mail

Aug 13, 2026

Evolent Health rated Buy despite heavy debt and losses, betting on strong growth by 2027. - Pluang

Aug 13, 2026

Evolent Health Q2 Earnings Review: Debt Is Distressing, But Business Is Booming (EVH) - Seeking Alpha

Aug 13, 2026

Truist Financial Sticks to Their Hold Rating for Evolent Health (EVH) - The Globe and Mail

Aug 13, 2026

Dimensional Fund Advisors LP Has $4.08 Million Stock Position in Evolent Health, Inc $EVH - marketbeat.com

Aug 13, 2026

Aug 12, 2026

EVH Maintained by Truist Securities -- Price Target Lowered to $6.00 - GuruFocus

Aug 12, 2026

Truist Financial Cuts Evolent Health (NYSE:EVH) Price Target to $6.00 - marketbeat.com

Aug 12, 2026

Truist Financial Maintains Evolent Health(EVH.US) With Hold Rating, Cuts Target Price to $6 - Moomoo

Aug 12, 2026

Truist cuts Evolent Health stock price target on execution risks By Investing.com - Investing.com Australia

Aug 12, 2026

Truist cuts Evolent Health stock price target on execution risks - Investing.com

Aug 12, 2026

Truist Securities Adjusts Price Target on Evolent Health to $6 From $7, Keeps Hold Rating - marketscreener.com

Aug 12, 2026

Aug 11, 2026

Evolent Health Shares Rise After Citigroup Upgrade - marketscreener.com

Aug 11, 2026

EVH Upgraded by Citigroup -- Price Target Lowered to $6.00 - GuruFocus

Aug 11, 2026

EVOLENT HEALTH, INC. : CITIGROUP RAISES TO BUY FROM NEUTRAL; CUTS TARGET PRICE TO $6 FROM $6.75 - Bitget

Aug 11, 2026